Posted on 3月 13, 20233/13/23
Accelerated Approval Pathways: Manufacturers Left to Grapple With Risk Versus Reward
Posted on 2月 22, 20232/22/23
Bringing a CPT Code to Life to Help in the Fight Against Cancer
Posted on 12月 22, 202212/22/22
Pivot Pros: How EVERSANA Course Corrected When the Market Changed
Posted on 11月 16, 202211/16/22
Case Study: Benchmarking Pathway-Specific Engagement with Health Plans & Organized Providers to Identify Best Practices
Posted on 11月 3, 202211/3/22
Payer Oncology Access Management in 2022
Posted on 9月 14, 20229/14/22
Point of Attack: Developing a Targeted Oncology Account Engagement Strategy and Tactical Platform
Posted on 7月 27, 20227/27/22
Commercialization Strategies in Oncology — The Right Partner Can Reduce Risk and Boost Rewards
Posted on 1月 14, 20221/14/22